Predicting Associations of MiRNAs and Candidate Gastric Cancer Genes for Nanomedicine

Overview

Journal Nanomaterials (Basel)

Date 2021 Apr 3

PMID 33801990

Citations 5

Authors

Aigul Akimniyazova

Anna Pyrkova

Vladimir Uversky

Anatoliy Ivashchenko

Affiliations

Soon will be listed here.

Abstract

Nanoscale miRNAs regulate the synthesis of most human proteins involved in differentiation, proliferation, cell cycle, apoptosis, and other processes associated with the growth and the development of an organism. miRNAs also play a number of important roles in the development of gastric cancer. In this work, we studied the quantitative characteristics of miRNA interactions with 69 candidate gastric cancer genes using bioinformatics approaches. To this end, the MirTarget program was used, which determines the characteristics of miRNA binding to mRNA in the 5'UTR, CDS, and 3'UTR. Associations of miRNAs with alternative target genes and associations of genes with alternative miRNAs were established. The cluster organization of miRNA binding sites (BSs) in mRNA was revealed, leading to the emergence of miRNA competition for binding to the mRNA of a target gene. Groups of target genes with clusters of overlapping BSs include miR-5095, miR-619-5p, miR-1273 family, miR-466, ID01030.3p-miR, ID00436.3p-miR, miR-574-5p, and ID00470.5p-miR. In the defined associations of target genes and miRNAs, miRNA BSs are organized into clusters of multiple BSs, which facilitate the design and the development of a system of chips that can be used to control the state of miRNA and target genes associations in gastric cancer.

Citing Articles

Developmental Biology: Computational and Experimental Approaches.

Ponomarenko M Int J Mol Sci. 2023; 24(13).

PMID: 37445614 PMC: 10341769. DOI: 10.3390/ijms241310435.

TAK-242 protects against oxygen-glucose deprivation and reoxygenation-induced injury in brain microvascular endothelial cells and alters the expression pattern of lncRNAs.

Kong L, Zhu S, Si M, Xu X, Yu J, Zhong W J Thorac Dis. 2023; 15(5):2571-2584.

PMID: 37324068 PMC: 10267908. DOI: 10.21037/jtd-23-360.

Endogenous piRNAs Can Interact with the Omicron Variant of the SARS-CoV-2 Genome.

Rakhmetullina A, Akimniyazova A, Niyazova T, Pyrkova A, Kamenova S, Kondybayeva A Curr Issues Mol Biol. 2023; 45(4):2950-2964.

PMID: 37185717 PMC: 10136802. DOI: 10.3390/cimb45040193.

piRNA and miRNA Can Suppress the Expression of Multiple Sclerosis Candidate Genes.

Kamenova S, Sharapkhanova A, Akimniyazova A, Kuzhybayeva K, Kondybayeva A, Rakhmetullina A Nanomaterials (Basel). 2023; 13(1).

PMID: 36615932 PMC: 9823834. DOI: 10.3390/nano13010022.

Identification of Bovine miRNAs with the Potential to Affect Human Gene Expression.

Myrzabekova M, Labeit S, Niyazova R, Akimniyazova A, Ivashchenko A Front Genet. 2022; 12:705350.

PMID: 35087564 PMC: 8787201. DOI: 10.3389/fgene.2021.705350.

References

Gu E, Song W, Liu A, Wang H . SCDb: an integrated database of stomach cancer. BMC Cancer. 2020; 20(1):490. PMC: 7265634. DOI: 10.1186/s12885-020-06869-3. View

Wang Y, Liu G, Sun S, Qin J . miR-1294 alleviates epithelial-mesenchymal transition by repressing FOXK1 in gastric cancer. Genes Genomics. 2019; 42(2):217-224. DOI: 10.1007/s13258-019-00899-3. View

Qu X, Zhao L, Zhang R, Wei Q, Wang M . Differential microRNA expression profiles associated with microsatellite status reveal possible epigenetic regulation of microsatellite instability in gastric adenocarcinoma. Ann Transl Med. 2020; 8(7):484. PMC: 7210178. DOI: 10.21037/atm.2020.03.54. View

Mukushkina D, Aisina D, Pyrkova A, Ryskulova A, Labeit S, Ivashchenko A . Prediction of miRNA Interactions With Candidate Atherosclerosis Gene mRNAs. Front Genet. 2020; 11:605054. PMC: 7672156. DOI: 10.3389/fgene.2020.605054. View

Zhou J, Su M, Zhang H, Wang J, Chen Y . miR-539-3P inhibits proliferation and invasion of gastric cancer cells by targeting CTBP1. Int J Clin Exp Pathol. 2020; 12(5):1618-1625. PMC: 6947129. View

Backes C, Meese E, Keller A . Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects. Mol Diagn Ther. 2016; 20(6):509-518. DOI: 10.1007/s40291-016-0221-4. View

Yin Y, Li X, Guo Z, Zhou F . MicroRNA‑381 regulates the growth of gastric cancer cell by targeting TWIST1. Mol Med Rep. 2019; 20(5):4376-4382. DOI: 10.3892/mmr.2019.10651. View

Ivashchenko A, Berillo O, Pyrkova A, Niyazova R, Atambayeva S . MiR-3960 binding sites with mRNA of human genes. Bioinformation. 2014; 10(7):423-7. PMC: 4135290. DOI: 10.6026/97320630010423. View

Feng C, She J, Chen X, Zhang Q, Zhang X, Wang Y . Exosomal miR-196a-1 promotes gastric cancer cell invasion and metastasis by targeting SFRP1. Nanomedicine (Lond). 2019; 14(19):2579-2593. DOI: 10.2217/nnm-2019-0053. View

10.

Stavast C, Erkeland S . The Non-Canonical Aspects of MicroRNAs: Many Roads to Gene Regulation. Cells. 2019; 8(11). PMC: 6912820. DOI: 10.3390/cells8111465. View

11.

Hrovatin K, Kunej T . Classification of miRNA-related sequence variations. Epigenomics. 2018; 10(4):463-481. DOI: 10.2217/epi-2017-0126. View

12.

Chen L, Heikkinen L, Wang C, Yang Y, Sun H, Wong G . Trends in the development of miRNA bioinformatics tools. Brief Bioinform. 2018; 20(5):1836-1852. PMC: 7414524. DOI: 10.1093/bib/bby054. View

13.

Bandara K, Michael M, Gleadle J . MicroRNA Biogenesis in Hypoxia. Microrna. 2017; 6(2):80-96. DOI: 10.2174/2211536606666170313114821. View

14.

Kabekkodu S, Shukla V, Varghese V, D Souza J, Chakrabarty S, Satyamoorthy K . Clustered miRNAs and their role in biological functions and diseases. Biol Rev Camb Philos Soc. 2018; 93(4):1955-1986. DOI: 10.1111/brv.12428. View

15.

Chen Q, Zhang F, Dong L, Wu H, Xu J, Li H . SIDT1-dependent absorption in the stomach mediates host uptake of dietary and orally administered microRNAs. Cell Res. 2020; 31(3):247-258. PMC: 8026584. DOI: 10.1038/s41422-020-0389-3. View

16.

Tafrihi M, Hasheminasab E . MiRNAs: Biology, Biogenesis, their Web-based Tools, and Databases. Microrna. 2018; 8(1):4-27. DOI: 10.2174/2211536607666180827111633. View

17.

Ivashchenko A, Berillo O, Pyrkova A, Niyazova R, Atambayeva S . The properties of binding sites of miR-619-5p, miR-5095, miR-5096, and miR-5585-3p in the mRNAs of human genes. Biomed Res Int. 2014; 2014:720715. PMC: 4137733. DOI: 10.1155/2014/720715. View

18.

Atambayeva S, Niyazova R, Ivashchenko A, Pyrkova A, Pinsky I, Akimniyazova A . The Binding Sites of miR-619-5p in the mRNAs of Human and Orthologous Genes. BMC Genomics. 2017; 18(1):428. PMC: 5452331. DOI: 10.1186/s12864-017-3811-6. View

19.

Rupaimoole R, Slack F . MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017; 16(3):203-222. DOI: 10.1038/nrd.2016.246. View

20.

Mellis D, Caporali A . MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target. Biochem Soc Trans. 2017; 46(1):11-21. DOI: 10.1042/BST20170037. View